CAS: 2438-32-6; (Z)-But-2-Enedioic Acid,(3S)-3-(4-Chlorophenyl)-N,N-Dimethyl-3-Pyridin-2-Ylpropan-1-Amine

该化合物是一种常用于缓解过敏症状的抗口炎,一种由氯苯胺,第一代抗口炎和甲酸组成的盐,其特点是能够选择性地阻塞H1类甲胺受体,从而减少喷雾,痒痒和鼻鼻涕等症状,通常通过口服,并因其镇静作用而闻名.该物质是白到白晶状粉,在水中可溶解,具有特定的光学旋转,表明其手性.其药理特征包括抗胆碱性,可导致副作用,如干嘴和晕眩.与许多抗口炎一样,在与其他中...

结构式图片

欧盟法规

C&L通报REACH预注册

上下游产品

CAS号113-92-8 扑尔敏

合成工艺路线路线简述

    扑尔敏置于β-环糊精体系中,用 Aq. Phosphate Buffer 用作溶剂,化学反应生成马来酸右氯苯那敏,(-)-2-(4-氯-Alpha-(2-(二甲基氨基)乙基)苄基)-吡啶马来酸盐(1:1)
    参考文献:β-环糊精开管毛细管电色谱柱的制备及其在十种碱性药物对映体分离中的应用.
    标题:β-环糊精开管毛细管电色谱柱的制备及其在十种碱性药物对映体分离中的应用.
    摘要:采用(3-巯基丙基)三甲氧基硅烷预衍生化将β-环糊精修饰的金纳米颗粒化学固定在新表面上,制备了开管毛细管电色谱柱.通过透射电子显微镜,扫描电子显微镜,红外光谱和紫外可见光谱对合成的纳米粒子和制备的柱进行了表征.当该柱用作手性固定相时,十种模型碱性药物没有观测到对映选择性.因此,将β-环糊精作为手性添加剂添加到背景电解质中,以期望可能发生协同效应并导致更好的分离.幸运的是,十对药物对映体的对映选择性得到了显着改善.然后,研究了β-环糊精浓度和背景电解质ph对手性分离的影响.采用所开发的分离模式,对佐匹克隆,马来酸氯苯那敏,马来酸溴苯那敏,盐酸二氧丙嗪,卡维地洛的所有对映体(文拉法辛除外)进行了基线分离,分辨率分别为 4.49,1.68,1.88,1.57,2.52,2.33,3.24,1.63 和 3.90分别为氢溴酸后马托品,甲基溴后马托品,文拉法辛,盐酸西布曲明和硫酸特布他林.此外,还讨论了所涉及的可能的分离机制.
    Doi:10.1371/journal.Pone.0146292

    海关参考信息

    专利信息


    专利号:US-9045788-B2
    优先权日:2012-07-17
    标题:Process for the enzymatic synthesis of (7S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl) N-methyl methanamine, and application in the synthesis of ivabradine and salts thereof
    发明人:PEDRAGOSA-MOREAU SANDRINE; LEFOULON FRANÇOIS; MORIS VARAS FRANCISCO; GONZALEZ SABIN JAVIER
    权利人:SERVIER LAB
    摘要:Process for the enzymatic synthesis of the compound of formula (I), (7S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)N-methyl methanamine: n nand application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid.

    专利号:US-6906046-B2
    优先权日:2000-12-22
    标题 :Pharmaceutical uses and synthesis of benzobicyclooctanes
    发明人:JACKSON RANDY W; DARWISH IHAB; BAUGHMAN TED A; HOWBERT J JEFFRY
    权利人:CELLTECH R & D INC
    摘要:Benzobicyclooctane compounds, their use in inhibiting cellular events involving TNF-α and IL-8, and in the treatment of inflammation events in general; a combinatorial library of diverse bicyclooctanes and process for their synthesis as a library and as individual compounds.

    专利号:US-2014024088-A1
    优先权日:2012-07-17
    标 题:Process for the enzymatic synthesis of (7s)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl) n-methyl methanamine, and application in the synthesis of ivabradine and salts thereof

    专利号:CA-2820192-C
    优先权日:2012-07-17
    标 题:Enzymatic synthesis process for (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, and application to the synthesis of ivabradine and of its salts

    专利号:CA-2820192-A1
    优先权日:2012-07-17
    标题:Enzymatic synthesis process for (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, and application to the synthesis of ivabradine and of its salts

    专利号:BR-102013017550-A2
    优先权日:2012-07-17
    标 题:(7s) -1- (3,4-Dimethoxy bicyclo [4. 2.0] octa-1,3,5-triene 7-yl) n-methyl methanamine enzymatic synthesis process and application to the synthesis of ivabradine and of its salts
    北京紫竹药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.zizhu-pharm.com
    电话: 010-65483355👤
    📞北京紫竹药业有限公司 ⚠️参考联系方式

    销售电话:010-65483355
    邮箱:jane@zizhu-pharm.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Le DC, Ngo TD, Hoa Le TH. Simultaneous Assay of Dexchlorpheniramine Maleate, Betamethasone, and Sodium Benzoate in Syrup by a Reliable and Robust HPLC Method. J Anal Methods Chem. 2019 Nov 29;2019:2952075. doi: 10.1155/2019/2952075.
    2: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. Dexchlorpheniramine. 2018 Oct 31. 16(4):e59-e67. doi: 10.1111/jocd.12349. Epub 2017 Jun 7. 28(4):488-495. doi: 10.1684/ejd.2018.3356. 42(2):126-132. doi: 10.1093/jat/bkx089. 83(6):633-639. doi: 10.1016/j.bjorl.2016.08.009. Epub 2016 Sep 13. 958(1-2):291-7. doi: 10.1016/s0021-9673(02)00314-x. 61(1):79-86. doi: 10.1111/j.1365-2125.2005.02524.x.
    9: Munch EP, Søborg M, Nørreslet TT, Mygind N. A comparative study of dexchlorpheniramine maleate sustained release tablets and budesonide nasal spray in seasonal allergic rhinitis. Allergy. 1983 Oct;38(7):517-24. doi: 10.1111/j.1398-9995.1983.tb02361.x. 1(8):449-52.

    合成参考文献


    参考文献:10.1007/s10637-011-9690-9
    摘要:Mir O, Alexandre J, Coriat R, Ropert S, Boudou-Rouquette P, Bui T, Chapron J, Durand JP, Dusser D, Goldwasser F. Safety of bevacizumab 7.5 mg/kg infusion over 10 minutes in NSCLC patients. Invest New Drugs. 2012 Aug;30(4):1756–60. doi: 10.1007/s10637-011-9690-9.
    参考文献:10.1007/s00216-010-3472-7
    摘要:Valderrama P, Romero AL, Imamura PM, Magalhães IRS, Bonato PS, Poppi RJ. Quantification of chlorpheniramine maleate enantiomers by ultraviolet spectroscopy and chemometric methods. Analytical and Bioanalytical Chemistry. 2010 Feb 11;397(1):181–8. doi: 10.1007/s00216-010-3472-7.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知